<DOC>
	<DOCNO>NCT01970787</DOCNO>
	<brief_summary>This Single-center prospective pilot trial involve 22 subject . This study assess feasibility , safety , efficacy radiofrequency ablation ( RFA ) anal canal use FDA clear HALO Ablation System eradicate anal HSIL lesion HIV-negative subject intra-anal intraepithelial neoplasia ( AIN ) . The study intervention demonstrate reasonable proportion subject histologically clear anal HSIL within ETZ tolerable relatively safe manner</brief_summary>
	<brief_title>A Trial Radiofrequency Ablation Anal Intraepithelial Neoplasia Using HALO Ablation System</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Squamous Intraepithelial Lesions Cervix</mesh_term>
	<criteria>Age 1875 year HRA 2 12 week prior 0 month RFA visit yield one flat , noncondylomatous biopsyproven HSILs 1 . Located entirely within eligible treatment zone 2 . Contiguous squamocolumnar junction Eligible treatment zone ( ETZ ) define 1 . 3 cm dentate line anocutaneous line 2 . Half anorectal circumference ( mean two contiguous quadrant ) If female childbearing age , negative pregnancy test within 8 week 0 month RFA visit declare intent remain birth control throughout trial , , declaration infertility define subject report status postmenopausal surgically sterile ( status post hysterectomy tubal ligation ) . HIV negative , ELISA/Western blot test obtain within 12 week 0 month RFA visit 1 . Any biopsyproven HSIL entirely outside ETZ 2 . Any biopsyproven HSIL partially within ETZ ( example , HSIL lesion extension perianal skin ) 3 . Any condylomas eligible treatment zone &gt; 1/2 cm diameter â€¢ Note : Condylomas eligible treatment zone &lt; 1/2 cm diameter must excise cauterize ( treat topically IRC ) Visit 1 ( 0 month RFA visit ) 4 . Any anal rectal pathology require treatment include ulcer , fistula , fissure , stenosis proctitis 5 . History present anal rectal cancer 6 . History pelvic radiation therapy 7 . History HPV vaccination plan initiate HPV vaccination trial 8 . History ablation resection therapy within ETZ cauterization excision condyloma ( ) 9 . History topical therapy ( Imiquimod , 5FU ) within 6 month prior 0 month RFA visit within ETZ 10 . Hemorrhoids &gt; grade II 11 . Fecal incontinence ( investigator feel may impair heal ) 12 . Concurrent disease require systemic immunosuppression therapy 13 . Concurrent malignancy require systemic therapy 14 . Life expectancy &lt; 2 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>